Workflow
广东肇庆星湖生物科技股份有限公司关于持股5%以上股东股份解除质押的公告

Core Viewpoint - The announcement details the release of share pledges by major shareholders of Guangdong Zhaoqing Xinghuo Biotechnology Co., Ltd., indicating a positive development in shareholder confidence and financial stability [1][2]. Group 1: Shareholder Information - As of the announcement date, the major shareholder, Ningxia Yipin Investment Group Co., Ltd. (Yipin Group), and its concerted actor, Tie Xiaorong, collectively hold 233,036,630 shares, accounting for 14.03% of the total share capital [1]. - Yipin Group holds 172,685,029 shares, representing 10.39% of the total share capital, while Tie Xiaorong holds 60,351,601 shares, which is 3.63% of the total share capital [1]. Group 2: Pledge Release Details - Yipin Group has released 89,351,604 shares from pledge, which is 51.74% of its pledged shares and 5.38% of the total share capital [1][2]. - Following the release of the pledge, Yipin Group and its concerted actors have no shares under pledge [1]. Group 3: Performance Commitment - In December 2023, Yipin Group and its concerted actors pledged 256,191,887 shares to Guangdong Province Guangxin Holdings Group Co., Ltd. as a guarantee for performance commitments [2]. - The performance commitments for the years 2022, 2023, and 2024 have been fulfilled, and there is no need for compensation to the listed company as of the end of the 2024 fiscal year [2]. Group 4: Future Plans - Yipin Group has confirmed that there are no plans for further share pledges following the release of the current pledges, and any future plans will be disclosed as necessary [3].